Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 12Sarcoma 1

Conditions

Sarcoma 16Ovarian Neoplasms 8Hemangiosarcoma 7Endometrial Neoplasms 7Carcinosarcoma 7Breast Neoplasms 6Sarcoma, Kaposi 4Neoplasms 4Melanoma 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Brain Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Glioblastoma 3Gastrointestinal Stromal Tumors 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3

Interventions

trametinib 1sotorasib 1pembrolizumab 1palbociclib 1atezolizumab 1Pemetrexed 1Panitumumab 1Paclitaxel 1Everolimus 1Drug Therapy 1Docetaxel 1Carboplatin 1Bevacizumab 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Paclitaxel × Sarcoma × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡